A. Marc Gillinov

Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention.

ClearFlow, Inc. develops surgical and medical devices. Its products are based on proprietary tube clearance technologies to resolve catheter clogging in other medical market segments, including urinary catheters, gastrointestinal catheters, and wound drainage. The company was founded by Andrew D. Firlik, Marc A. Gillinov and Edward M. Boyle Jr. in 2006 and is headquartered in Irvine, CA.

Part of Caris Life Sciences, LLC, Cleveland Clinic Hospital is a general and surgical hospital. The company is based in Weston, FL. Cleveland Clinic Hospital was acquired by The Cleveland Clinic Foundation, a subsidiary of Caris Life Sciences, LLC from Tenet Healthcare Corp. on October 02, 2006.

Founded in 2001, Foundation Medical Partners is a venture capital firm located in Rowayton, Connecticut. The firm is affiliated with the Cleveland Clinic